These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 643973)

  • 1. [Fibrin(ogen degradation product concentration (SFP) as a diagnostic parameter for the differentiation of artifical and essential blood in cerebrospinal fluid].
    Hindersin P; Heidrich R
    Psychiatr Neurol Med Psychol (Leipz); 1978 Jan; 30(1):36-9. PubMed ID: 643973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fibrinogen degradation products in human CSF: a preliminary clinical study].
    Li YP
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Jun; 19(3):142-5. PubMed ID: 3757627
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of cerebrospinal fluid from patients with psychiatric and neurological disorders by two-dimensional electrophoresis: identification of disease-associated polypeptides as fibrin fragments.
    Wildenauer DB; Körschenhausen D; Hoechtlen W; Ackenheil M; Kehl M; Lottspeich F
    Electrophoresis; 1991; 12(7-8):487-92. PubMed ID: 1915241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro studies to elucidate the fibrinolytic activity in cerebrospinal fluid altered by inflammation and hemorrhage and having pathologic protein values].
    Hindersin P; Heidrich R
    Psychiatr Neurol Med Psychol (Leipz); 1977 Aug; 29(8):465-73. PubMed ID: 144927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrin-fibrinogen degradation products in cerebrospinal fluid of patients with meningococcal infections (author's transl)].
    Bajo R; Vaca R; Elduayen R; Zarallo L; Cardesa JJ; Pérez-Miranda M
    Med Clin (Barc); 1980 Nov; 75(8):338-41. PubMed ID: 7442335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoglobulins A, M and G, fibrinogen degradation products (FFDP) and alkaline phosphatase activity in the cerebrospinal fluid in differential diagnosis of meningitis in children].
    Rudobielska M; Szafrańska M; Zoch-Zwierz W; Myśliwiec B
    Pol Tyg Lek; 1980 Aug; 35(34):1293-5. PubMed ID: 7443556
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of fibrin fibrinogen degradation products in the cerebrospinal fluid in the neonatal period].
    Dalens B; Bezou MJ; Coulet M; Raynaud EJ
    Ann Pediatr (Paris); 1983 Jan; 30(1):59-62. PubMed ID: 6830109
    [No Abstract]   [Full Text] [Related]  

  • 8. D-dimer levels in the cerebrospinal fluid: a marker of central nervous system involvement in neoplastic disease.
    Eclache V; Vu T; Le Roux G
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):321-4. PubMed ID: 7971253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of fibrin-fibrinogen degradation products (FFDP) in the diagnosis of meningitis in children].
    Myśliwiec B
    Pediatr Pol; 1980 Apr; 55(4):421-6. PubMed ID: 7413304
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
    Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M
    J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catabolism of purified rat fibrin(ogen) plasmin degradation products in rats.
    Nieuwenhuizen W; Emeis JJ; Vermond A
    Thromb Haemost; 1982 Aug; 48(1):59-61. PubMed ID: 7135343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [FDP levels in the cerebrospinal fluid are elevated in patients with meningitis].
    Okamoto S; Takahashi H; Minoura K; Fujita N; Yoshimura M
    Rinsho Byori; 1991 Jun; 39(6):651-5. PubMed ID: 1880942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinogen degradation products in the cerebrospinal fluid of children with lymphoblastic leukemia].
    Borkowski W; Kolanowska H; Depowska T; Kaczor Z
    Pediatr Pol; 1981 Sep; 56(9):1017-20. PubMed ID: 6948264
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrinogen degradation products in the cerebrospinal fluid in central nervous system diseases].
    Kolanowska H; Solecka B
    Pol Przegl Chir; 1980 Aug; 52(8):729-34. PubMed ID: 7433284
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of internal hemorrhage on fibrin(ogen) degradation products in canine blood.
    McCaw DL; Jergens AE; Turrentine MA; Johnson GS
    Am J Vet Res; 1986 Jul; 47(7):1620-1. PubMed ID: 3740635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of urinary protein C inhibitor to fibrin(ogen) and its binding mechanism.
    Hayashi S; Yamada K
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):153-8. PubMed ID: 8384496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasminogen concentration in the cerebrospinal fluid of patients with various neurological diseases (author's transl)].
    Maruyama I; Igata A
    Rinsho Shinkeigaku; 1979 Aug; 19(8):481-5. PubMed ID: 498662
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrin-fibrinogen degradation products in cerebrospinal fluid.
    Brueton MJ; Breeze GR; Stuart J
    J Clin Pathol; 1976 Apr; 29(4):341-4. PubMed ID: 932226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Signification of fibrinogen degradation (FDP) product in CSF during the neonatal period (author's transl)].
    Dalens B; Bezou MJ; Coulet M; Raynaud EJ
    Pathol Biol (Paris); 1981 Dec; 29(10):605-8. PubMed ID: 7041056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.
    Cioni G; Cristani A; Mussini C; Grandi S; Pentore R; Zeneroli ML; Tizzanini W; Zagni G; Ventura E
    Ital J Gastroenterol; 1990 Apr; 22(2):70-4. PubMed ID: 2131934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.